← Who reports today · Health Care
DGX earnings date & Q2 2026 results · Quest Diagnostics
US GAAP · $M · vs Q2 2025 · quarter ended 06/30/2026 · reported 07/23/2026
Quest Diagnostics Incorporated is an American clinical laboratory. · Text: Wikipedia, CC BY-SA 4.0, abridged
More about the company
A Fortune 500 company, Quest operates in the United States, Puerto Rico, Mexico, and Brazil. Quest also maintains collaborative agreements with various hospitals and clinics across the globe.
Key growth driver: Organic revenue grew 10.0%, and adjusted diluted EPS of $3.12 was up 19.1%. · by the Q2 2026 report
When is DGX’s next earnings date?
Tuesday, October 20, 2026estimated
Expected around Oct 20 — based on last year’s report on Oct 21, 2025. We have not yet seen the company's announcement of the date.
How we estimate
The estimate is the date of the same-quarter report a year ago, per the company’s SEC filing, moved forward 52 weeks (same weekday). Companies usually keep the same week; the date will be replaced once DGX announces it.
Same quarter a year ago (ended September 30, 2025): revenue $2.816B, EPS (GAAP) $2.16
How we calculate
Year-ago figures are GAAP, from the company's SEC filings (XBRL); EPS is diluted.
What time does DGX report? Usually before market open: the last 4 results releases reached the SEC at 6:46 am, 6:48 am, 6:53 am, 4:37 pm ET.
Last report: Jul 23, 2026 (Q2 2026) — broken down in the Sankey chart below. Dates: company announcements; past dates and times — SEC 8-K filings. Who else reports this week →
All figures in $M.
Revenue
$3,043
+10.2%
Operating income
$459
+4.8%
15.1% margin
Net income
$320
+13.5%
$2.84/sh · 10.5% margin
Verdict: Quest Diagnostics' revenues rose 10.2% to $3.04B and net income attributable to Quest grew 13.5% to $320M, lifting diluted EPS 15.0% to $2.84.
Full year 2026 revenues are now expected between $11.95 billion and $12.05 billion, and reported diluted EPS between $9.97 and $10.17.
Source and notation
Source: DGX press release, 8-K EX-99.1 of 07/23/2026 (SEC EDGAR).
Open the chart as a PNG image ↗ · for sharing and presentations · free to reuse, CC BY 4.0
DGX earnings history: past report dates
| Jul 23, 2026 Thu | 6:46 ambefore market open | Jun 30, 2026 | $3.0B+10% y/y | $2.84+15% y/y |
| Apr 21, 2026 Tue | 6:48 ambefore market open | Mar 31, 2026 | $2.9B+9% y/y | $2.24+15% y/y |
| Jan 12, 2026 Mon | 4:37 pmafter market close | Dec 31, 2025 | ≈$2.8B+7% y/y | ≈$2.18+12% y/y |
| Oct 21, 2025 Tue | 6:50 ambefore market open | Sep 30, 2025 | $2.8B+13% y/y | $2.16+9% y/y |
| Jul 22, 2025 Tue | 6:48 ambefore market open | Jun 30, 2025 | $2.8B+15% y/y | $2.47+22% y/y |
| Apr 22, 2025 Tue | 6:44 ambefore market open | Mar 31, 2025 | $2.7B+12% y/y | $1.94+13% y/y |
| Jan 30, 2025 Thu | 6:47 ambefore market open | Dec 31, 2024 | ≈$2.6B+15% y/y | ≈$1.95+15% y/y |
| Oct 22, 2024 Tue | 6:48 ambefore market open | Sep 30, 2024 | $2.5B+8% y/y | $1.99+2% y/y |
| Jul 23, 2024 Tue | 6:46 ambefore market open | Jun 30, 2024 | $2.4B+3% y/y | $2.03−1% y/y |
| Apr 23, 2024 Tue | 6:47 ambefore market open | Mar 31, 2024 | $2.4B+2% y/y | $1.72−3% y/y |
| Feb 1, 2024 Thu | 6:49 ambefore market open | Dec 31, 2023 | ≈$2.3B−2% y/y | ≈$1.70+85% y/y |
| Oct 24, 2023 Tue | 6:47 ambefore market open | Sep 30, 2023 | $2.3B−8% y/y | $1.96−10% y/y |
| Jul 26, 2023 Wed | 6:48 ambefore market open | Jun 30, 2023 | $2.3B−5% y/y | $2.05+5% y/y |
| Apr 27, 2023 Thu | 6:47 ambefore market open | Mar 31, 2023 | $2.3B−11% y/y | $1.78−39% y/y |
| Feb 2, 2023 Thu | 6:49 ambefore market open | Dec 31, 2022 | ≈$2.3B−15% y/y | ≈$0.92−71% y/y |
| Oct 20, 2022 Thu | 6:47 ambefore market open | Sep 30, 2022 | $2.5B−10% y/y | $2.17−46% y/y |
| Jul 21, 2022 Thu | 6:48 ambefore market open | Jun 30, 2022 | $2.5B−4% y/y | $1.96−60% y/y |
| Apr 21, 2022 Thu | 6:48 ambefore market open | Mar 31, 2022 | $2.6B−4% y/y | $2.92−16% y/y |
| Jan 12, 2022 Wed | 6:48 ambefore market open | Dec 31, 2021 | ≈$2.7B−9% y/y | ≈$3.14−25% y/y |
| Oct 21, 2021 Thu | 6:50 ambefore market open | Sep 30, 2021 | $2.8B−0% y/y | $4.02−3% y/y |
| Jul 22, 2021 Thu | 6:47 ambefore market open | Jun 30, 2021 | $2.5B+40% y/y | $4.96+265% y/y |
| Apr 22, 2021 Thu | 6:49 ambefore market open | Mar 31, 2021 | $2.7B+49% y/y | $3.46+374% y/y |
| Feb 4, 2021 Thu | 6:48 ambefore market open | Dec 31, 2020 | $3.0B+56% y/y | $4.21+126% y/y |
| Oct 22, 2020 Thu | 6:53 ambefore market open | Sep 30, 2020 | $2.8B+42% y/y | $4.14+165% y/y |
| Jul 13, 2020 Mon | 6:58 ambefore market open | Jun 30, 2020 | $1.8B−6% y/y | $1.36−18% y/y |
| Apr 22, 2020 Wed | 6:51 ambefore market open | Mar 31, 2020 | $1.8B−4% y/y | $0.73−39% y/y |
| Jan 30, 2020 Thu | 6:51 ambefore market open | Dec 31, 2019 | $1.9B+5% y/y | $1.86+102% y/y |
| Oct 22, 2019 Tue | 6:51 ambefore market open | Sep 30, 2019 | $2.0B+4% y/y | $1.56+2% y/y |
| Jul 23, 2019 Tue | 6:53 ambefore market open | Jun 30, 2019 | $2.0B+2% y/y | $1.66+6% y/y |
| Apr 23, 2019 Tue | 7:06 ambefore market open | Mar 31, 2019 | $1.9B+0% y/y | $1.20−6% y/y |
| Feb 14, 2019 Thu | 6:50 ambefore market open | Dec 31, 2018 | $1.8B−1% y/y | $0.92−49% y/y |
| Oct 23, 2018 Tue | 6:48 ambefore market open | Sep 30, 2018 | $1.9B+2% y/y | $1.53+33% y/y |
| Jul 24, 2018 Tue | 6:52 ambefore market open | Jun 30, 2018 | $1.9B+3% y/y | $1.57+15% y/y |
| Apr 19, 2018 Thu | 6:50 ambefore market open | Mar 31, 2018 | $1.9B+4% y/y | $1.27+9% y/y |
| Feb 1, 2018 Thu | 6:50 ambefore market open | Dec 31, 2017 | $1.9B+0% y/y | $1.82+67% y/y |
| Jul 25, 2017 Tue | 6:54 ambefore market open | Jun 30, 2017 | $1.9B−2% y/y | $1.37+0% y/y |
| Apr 20, 2017 Thu | 6:50 ambefore market open | Mar 31, 2017 | $1.8B−2% y/y | $1.16+63% y/y |
| Jan 26, 2017 Thu | 6:59 ambefore market open | Dec 31, 2016 | $1.9B+1% y/y | $1.09−16% y/y |
| Oct 20, 2016 Thu | 6:49 ambefore market open | Sep 30, 2016 | $1.9B+0% y/y | $1.34−43% y/y |
| Jul 21, 2016 Thu | 6:50 ambefore market open | Jun 30, 2016 | $1.9B−1% y/y | $1.37+69% y/y |
| Apr 21, 2016 Thu | 6:49 ambefore market open | Mar 31, 2016 | $1.9B+1% y/y | $0.71+69% y/y |
| Jan 28, 2016 Thu | 6:50 ambefore market open | Dec 31, 2015 | $1.8B−2% y/y | $1.29+0% y/y |
| Oct 22, 2015 Thu | 6:59 ambefore market open | Sep 30, 2015 | $1.9B−1% y/y | $2.35+167% y/y |
| Jul 23, 2015 Thu | 7:03 ambefore market open | Jun 30, 2015 | $1.9B+1% y/y | $0.81−12% y/y |
| Apr 23, 2015 Thu | 7:05 ambefore market open | Mar 31, 2015 | $1.8B+5% y/y | $0.42−41% y/y |
| Jan 29, 2015 Thu | 7:03 ambefore market open | Dec 31, 2014 | $1.9B+7% y/y | $1.29+33% y/y |
| Oct 23, 2014 Thu | 7:04 ambefore market open | Sep 30, 2014 | $1.9B+6% y/y | $0.88−67% y/y |
| Jul 24, 2014 Thu | 7:12 ambefore market open | Jun 30, 2014 | $1.9B+5% y/y | $0.92−14% y/y |
| Apr 24, 2014 Thu | 7:09 ambefore market open | Mar 31, 2014 | $1.7B−2% y/y | $0.71−16% y/y |
| Jan 30, 2014 Thu | 7:06 ambefore market open | Dec 31, 2013 | $1.8B−1% y/y | $0.97+185% y/y |
| Oct 10, 2013 Thu | 4:37 pmafter market close | Sep 30, 2013 | $1.8B−2% y/y | $2.68+165% y/y |
| Jul 18, 2013 Thu | 7:18 ambefore market open | Jun 30, 2013 | $1.8B−3% y/y | $1.07−4% y/y |
| Apr 17, 2013 Wed | 7:10 ambefore market open | Mar 31, 2013 | $1.8B−6% y/y | $0.85−14% y/y |
| Jan 16, 2013 Wed | 7:41 ambefore market open | Dec 31, 2012 | $1.8B−4% y/y | $0.34−71% y/y |
| Oct 17, 2012 Wed | 7:06 ambefore market open | Sep 30, 2012 | $1.8B−3% y/y | $1.01−6% y/y |
| Jul 19, 2012 Thu | 6:45 ambefore market open | Jun 30, 2012 | $1.9B+0% y/y | $1.11+9% y/y |
| Apr 18, 2012 Wed | 7:09 ambefore market open | Mar 31, 2012 | $1.9B+6% y/y | $0.99 |
| Jan 24, 2012 Tue | 7:09 ambefore market open | Dec 31, 2011 | $1.8B | $1.19 |
Show all 58 reports since 2012Show fewer
How we count
Report date and time — when the company filed its results press release with the SEC (Form 8-K, Item 2.02); the regular session runs 9:30 am – 4:00 pm ET. Companies that file the 8-K late in the evening publish the release the next morning: the date is that morning, before market open, and the evening filing time is not shown. Revenue and diluted EPS — the company’s XBRL filings, EPS adjusted for stock splits; ≈ — fourth quarter derived as full year minus three quarters. Source: SEC EDGAR.
Quest Diagnostics: 15-year financials
| 2025 | 11,035 | 1,556 | 992 | 1,359 | 353 |
| 2024 | 9,872 | 1,346 | 871 | 909 | 331 |
| 2023 | 9,252 | 1,262 | 854 | 864 | 314 |
| 2022 | 9,883 | 1,428 | 946 | 1,314 | 305 |
| 2021 | 10,788 | 2,381 | 1,995 | 1,830 | 309 |
| 2020 | 9,437 | 1,971 | 1,431 | 1,587 | 297 |
| 2019 | 7,726 | 1,231 | 858 | 843 | 286 |
| 2018 | 7,531 | 1,101 | 736 | 817 | 266 |
| 2017 | 7,402 | 1,165 | 772 | 923 | 247 |
| 2016 | 7,214 | 1,277 | 645 | 823 | 223 |
| 2015 | 7,493 | 1,399 | 709 | 558 | 212 |
| 2014 | 7,435 | 983 | 556 | 636 | 187 |
| 2013 | 7,146 | 1,475 | 849 | 421 | 185 |
| 2012 | 7,383 | 1,201 | 556 | 1,005 | 108 |
| 2011 | 7,392 | 987 | 471 | 734 | 65 |
Show all 15 yearsShow fewer
$ millions, annual 10-K reports on SEC EDGAR (US GAAP)*.
How we calculate
Figures are annual report lines; if a year was later restated (discontinued operations, mergers), we use the latest filing that shows it. Free cash flow is operating cash flow minus capital expenditures; dividends are cash paid to common shareholders during the year. “—” means the line isn’t in the filing. The table starts in 2011; where the listed issuer changed (holding reorganization, redomicile), earlier years come from the predecessor’s filings.
Shareholders’ equity at Jun 30, 2026: $7.5B (44% of total assets). Compare with other S&P 500 companies →
Included in screener lists: S&P 500 companies that paid dividends 10 years without a gap
Quest Diagnostics (DGX) earnings: FAQ
When is DGX's next earnings date?
We have not yet seen an announcement of the date from Quest Diagnostics (DGX). Based on last year's report on Oct 21, 2025, the next report is expected around Oct 20, 2026.
What time does DGX report earnings?
Quest Diagnostics usually reports before market open: its latest results release was filed with the SEC at 6:46 am ET on Jul 23, 2026.
When did DGX last report earnings?
Quest Diagnostics reported Q2 2026 results on Jul 23, 2026.
Where can I find Quest Diagnostics's financial statements?
On SEC EDGAR: quarterly reports (10-Q), the annual report (10-K) and earnings releases (8-K). The “Verified” badge next to the chart links to DGX's filings; this page breaks the latest report down in a Sankey chart.
What was DGX's net income in Q2 2026?
Quest Diagnostics reported net income of $320M for Q2 2026 (+13.5% year over year), under US GAAP.
Does Quest Diagnostics pay dividends?
Yes. In 2025, Quest Diagnostics paid $353M in dividends on its common stock, per its 10-K. Earlier years are in the 15-year table above.
How has Quest Diagnostics's revenue changed since 2011?
Per its 10-K filings, revenue grew 1.5x: $7,392M in 2011 and $11,035M in 2025. The latest year is the highest in the table. Year-by-year figures are in the table above.
New to earnings reports? Start with how to read an earnings report.
How this page was made: the figures come from the company's own report on SEC EDGAR; the summary and nuances were drafted by our model from that report — two independent automated readings of the release had to match, and every number in the text was checked against it. Figures checked against the filing on 10/16/2026. How we make the breakdowns · Report an error
More reports: DHR · Q2 2026 · DXCM · Q2 2026 · ELV · Q2 2026 · GEHC · Q2 2026 · GILD · Q2 2026 · HCA · Q2 2026 · ILMN · Q2 2026 · INCY · Q2 2026 · IQV · Q2 2026 · ISRG · Q2 2026 · all reports